TAVR Appears to Be Reasonable Treatment for Higher-Risk Patients with Bicuspid Aortic Stenosis
Transcatheter aortic valve replacement (TAVR) showed reasonable outcomes in patients with bicuspid aortic valves who were at increased risk for surgical mortality, according to a new analysis of the Transcatheter Valve Therapies (TVT) Registry.